A prospective, exploratory study of Retlirafusp alfa combined with FLOT as neoadjuvant therapy for patients with resectable adenocarcinoma of the esophagogastric junction

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 91ce19da20488ae47255c1e27cfa3f10d69a1f6e
First added on: May 09, 2026